Literature DB >> 1519064

SV2, a brain synaptic vesicle protein homologous to bacterial transporters.

S M Bajjalieh1, K Peterson, R Shinghal, R H Scheller.   

Abstract

Synaptic vesicle protein 2 (SV2) is a membrane glycoprotein specifically localized to secretory vesicles in neurons and endocrine cells. As a first step toward understanding the function of SV2 in neural secretion, a rat brain complementary DNA (cDNA) that encodes SV2 was isolated and characterized. Analyses of this cDNA predict that SV2 contains 12 transmembrane domains. The NH2-terminal half of the protein shows significant amino acid sequence identity to a family of bacterial proteins that transport sugars, citrate, and drugs. Expression of the SV2 cDNA in COS cells yielded a high level of SV2-like immunoreactivity distributed in a reticular and punctate pattern, which suggests localization to intracellular membranes. Its localization to vesicles, predicted membrane topology, and sequence identity to known transporters suggest that SV2 is a synaptic vesicle-specific transporter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1519064     DOI: 10.1126/science.1519064

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  69 in total

Review 1.  Synaptic vesicle proteins and neuronal plasticity in adrenergic neurons.

Authors:  X E Hou; A Dahlström
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Synaptic vesicle protein 2, A new neuroendocrine cell marker.

Authors:  G M Portela-Gomes; A Lukinius; L Grimelius
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Alpha-synuclein loss in spinal muscular atrophy.

Authors:  Gyula Acsadi; Xingli Li; Kelley J Murphy; Kathryn J Swoboda; Graham C Parker
Journal:  J Mol Neurosci       Date:  2010-07-17       Impact factor: 3.444

4.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

Review 5.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

6.  Interaural timing difference circuits in the auditory brainstem of the emu (Dromaius novaehollandiae).

Authors:  Katrina M MacLeod; Daphne Soares; Catherine E Carr
Journal:  J Comp Neurol       Date:  2006-03-10       Impact factor: 3.215

7.  Phosphatidylinositol-4-kinase type II alpha contains an AP-3-sorting motif and a kinase domain that are both required for endosome traffic.

Authors:  Branch Craige; Gloria Salazar; Victor Faundez
Journal:  Mol Biol Cell       Date:  2008-02-06       Impact factor: 4.138

8.  Brain contains two forms of synaptic vesicle protein 2.

Authors:  S M Bajjalieh; K Peterson; M Linial; R H Scheller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

10.  Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.

Authors:  V Daniels; M Wood; K Leclercq; R M Kaminski; M Gillard
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.